ES2054620T3 - Una particula que comprende un nucleo revestido. - Google Patents

Una particula que comprende un nucleo revestido.

Info

Publication number
ES2054620T3
ES2054620T3 ES86850360T ES86850360T ES2054620T3 ES 2054620 T3 ES2054620 T3 ES 2054620T3 ES 86850360 T ES86850360 T ES 86850360T ES 86850360 T ES86850360 T ES 86850360T ES 2054620 T3 ES2054620 T3 ES 2054620T3
Authority
ES
Spain
Prior art keywords
liquid
coating
nucleum
particle
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86850360T
Other languages
English (en)
Inventor
Bengt Goran Berglund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Application granted granted Critical
Publication of ES2054620T3 publication Critical patent/ES2054620T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Glanulating (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)

Abstract

ESTA INNOVACION SE REFIERE A UNA PARTICULA QUE CONTIENE UNA SUSTANCIA ACTIVA SOLUBLE EN LIQUIDO PARA FUNCIONAMIENTO FUERA DE UN CUERPO HUMANO O UN ANIMAL, LLAMADA PAARTICULA QUE CONTIENE UN NUCLEO CON UN REVESTIMIENTO POR ENCIMA, DICHO REVESTIMIENTO COMPRENDE UNA SUSTANCIA ACTIVA SOLUBLE EN LIQUIDO. SE CARACTERIZA EN QUE SU NUCLEO POSEE UNA APARIENCIA DIFERENTE DE LA DEL REVESTIMIENTO, Y EN QUE LA APARIENCIA DEL NUCLEO ESTA OCULTA INICIALMENTE POR EL RECUBRIMIENTO Y APARECE DESPUES DE LA DISOLUCION DE LA SUSTANCIA ACTIVA SOLUBLE EN LIQUIDO, INDICANDO DE ESE MODO QUE LA SUSTANCIA ACTIVA HA SIDO DISUELTA EN DICHO REVESTIMIENTO. EL INVENTO HA SIDO APLICADO PRINCIPALMENTE SOBRE GRANULOS, TABLETAS Y UNIDADES DE DISTRIBUCION DE FARMACOS SIMILARES, QUE FORMAN PARTE DE UN LIQUIDO PARENTERAL DENTRO DEL PROGRAMA DE ADMINISTRACION.
ES86850360T 1985-10-25 1986-10-21 Una particula que comprende un nucleo revestido. Expired - Lifetime ES2054620T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505034A SE8505034D0 (sv) 1985-10-25 1985-10-25 Kropp bestaende av en kerna med ett overdrag

Publications (1)

Publication Number Publication Date
ES2054620T3 true ES2054620T3 (es) 1994-08-16

Family

ID=20361912

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86850360T Expired - Lifetime ES2054620T3 (es) 1985-10-25 1986-10-21 Una particula que comprende un nucleo revestido.

Country Status (20)

Country Link
EP (1) EP0220151B1 (es)
JP (1) JPH0774148B2 (es)
CN (1) CN86107223A (es)
AT (1) ATE88630T1 (es)
AU (1) AU586290B2 (es)
CA (1) CA1294834C (es)
DD (1) DD268863A5 (es)
DE (1) DE3688355T2 (es)
DK (1) DK504186A (es)
ES (1) ES2054620T3 (es)
FI (1) FI92552C (es)
HK (1) HK124495A (es)
HU (1) HUT42323A (es)
IE (1) IE60165B1 (es)
MY (1) MY100335A (es)
NO (1) NO173589C (es)
PH (1) PH22291A (es)
PT (1) PT83614B (es)
SE (1) SE8505034D0 (es)
ZA (1) ZA867787B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE657254C (de) * 1935-02-25 1938-02-26 Alfred Knopp Dipl Ing Vorrichtung zum Erhitzen von Buegeleisen
DE657259C (de) * 1936-05-20 1938-03-01 Ludwig Heumann & Co Chem Pharm Pressling fuer pharmazeutische Zwecke
GB800973A (en) * 1954-08-13 1958-09-03 Sterling Drug Inc Improvements in or relating to pills or tablets
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release

Also Published As

Publication number Publication date
DE3688355T2 (de) 1993-12-09
NO864185D0 (no) 1986-10-20
FI92552B (fi) 1994-08-31
FI92552C (sv) 1994-12-12
JPS62106010A (ja) 1987-05-16
FI864321L (fi) 1987-04-26
JPH0774148B2 (ja) 1995-08-09
ZA867787B (en) 1987-08-26
FI864321A0 (fi) 1986-10-24
NO864185L (no) 1987-04-27
NO173589B (no) 1993-09-27
DD268863A5 (de) 1989-06-14
PT83614A (en) 1986-11-01
DK504186A (da) 1987-04-26
CN86107223A (zh) 1987-07-01
EP0220151A1 (en) 1987-04-29
IE862817L (en) 1987-04-25
HK124495A (en) 1995-08-11
DE3688355D1 (de) 1993-06-03
DK504186D0 (da) 1986-10-21
PT83614B (en) 1988-11-21
CA1294834C (en) 1992-01-28
AU6419786A (en) 1987-04-30
SE8505034D0 (sv) 1985-10-25
AU586290B2 (en) 1989-07-06
IE60165B1 (en) 1994-06-15
HUT42323A (en) 1987-07-28
EP0220151B1 (en) 1993-04-28
ATE88630T1 (de) 1993-05-15
PH22291A (en) 1988-07-22
MY100335A (en) 1990-08-28
NO173589C (no) 1994-01-05

Similar Documents

Publication Publication Date Title
AU560829B2 (en) Continuous release pharmaceutical compositions
ECSP941148A (es) Medicamento en forma de comprimido con liberacion retardada de substancia activa
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
ATE128863T1 (de) Arzneimittelformulierungen mit verzögerter wirkstoffabgabe.
DE3877764D1 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
ES517444A0 (es) Procedimiento para obtener medicamentos altamente solubles por atomizacion en presencia de un estabilizante y un agente inhibidor de formacion de cristales.
GB1346609A (es)
NL151639B (nl) Werkwijze ter bereiding van een middel ter voorkoming van het samenbakken van kunstmest.
EP0202445A3 (en) Pharmaceutical deposition forms containing antitumour agents
NL195083C (nl) Preparaat voor de afgifte van een samenstelling van een heilzaam middel.
ES2029228T3 (es) Procedimiento para la produccion de un preparado retardado de ibuprofeno.
IE820177L (en) Coated coloured intagliated articles.
DE69404116D1 (de) Mit Zucker überzogene pharmazeutische Dosierungseinheit
GB1204580A (en) Pharmaceutical dosage forms
NL142890B (nl) Werkwijze voor de vervaardiging van een samengesteld lichaam.
CO5050328A1 (es) Sistema solvente para la mejor penetracion de compuestos farmaceuticos
NL175882B (nl) Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
NL194715B (nl) Preparaat voor de afgifte van een samenstelling van een heilzaam middel.
NL161434B (nl) Werkwijze voor de bereiding van farmaceutische prepara- ten met alfa-sympathicolytische werking, gevormde pre- paraten en werkwijze voor de bereiding van aminoalkyl- tetrahydro 1-ketonaftaleenderivaten.
NL141784B (nl) Werkwijze voor het bereiden van benzothiazepinederivaten en dergelijke verbindingen bevattende therapeutische preparaten.
NL150099B (nl) Werkwijze voor het bereiden van een preparaat met lokaal-anesthetische activiteit, gevormd preparaat en werkwijze voor het bereiden van een verbinding, geschikt voor de bereiding van een dergelijk preparaat.
NL143573B (nl) Werkwijze voor het bereiden van farmacologisch werkzame 1,4-tetrahydro-oxazinen, en van farmaceutische preparaten met een kalmerende en/of analgetische en/of anti-inflammatoire werking, die een of meer van deze verbindingen bevatten.
AU586290B2 (en) A particle comprising a coated core
ES2148578T3 (es) Soporte de medicamento para un inhalador de polvo seco y procedimiento de fabricacion del mismo.
NO881474D0 (no) Emballasje som hindrer skumdannelse, fremgangsmaate til fremstilling av en slik emballasje samt skumdempende middel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 220151

Country of ref document: ES